Blog

CADTH has received a submission from Actavis Speciality Pharmaceuticals for Constella (linaclotide) for patients with irritable bowel syndrome (IBS) with constipation. ...

Healthcare guidance body NICE has today published final guidance recommending sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) as treatment ...

Merck & Co's cancer drug Keytruda, which works by boosting the immune system but has yet to be licensed in ...

[:content [\1 \7 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \space \T \h \e \  \c \o \s \t \space \o \f \space \p \r \e \s \c \r \i \b \i \n \g \space \d \r \u \g \s \space \i \n \space \S \c \o \t \l \a \n \d \space \h \a \s \space \i \n \c \r \e \a \s \e \d \space \b \y \space \Â \£ \6 \. \7 \space \m \i \l \l \i \o \n \space \i \n \space \a \space \y \e \a \r \. \  \P \a \y \m \e \n \t \s \space \t \o \space \p \h \a \r \m \a \c \i \s \t \s \, " ..."]]

Roche today announced that Health Canada has approved a subcutaneous (SC) formulation of ACTEMRA (tocilizumab) for the treatment of adults ...

People with hormone-relapsed prostate cancer that has spread to other parts of the body and have been treated with the ...

The Canadian Drug Expert Committee (CDEC) has recommended that simeprevir, in combination with peginterferon alfa and ribavirin be listed for the treatment ...

[:content [\A \f \l \i \b \e \r \c \e \p \t \space \( \Z \a \l \t \r \a \p \) \  \i \s \space \n \o \t \space \r \e \c \o \m \m \e \n \d \e \d \space \f \o \r \space \u \s \e \space \w \i \t \h \i \n \space \N \H \S \space \S \c \o \t \l \a \n \d \space \f \o \r \space \u \s \e \  \i \n \space \c \o \m \b \i \n \a \t \i \o \n \space \w \i \t \h \space \i \r \i \n \o \t \e \c \a \n \/ \5 \- \f \l \u \o \r \o \u \r \a \c \i \l \/ \f \o \l \i \n \i \c \space \a \c \i \d \space \( \F \O \L \F \I \R \I \) \space \c \h \e \m \o \t \h \e \r \a \p \y \, \space \a \f \l \i \b \e \r \c \e \p \t \space \i \s \space \i \n \d \i \c \a \t \e \d " ..."]]

Boehringer Ingelheim (Canada) Ltd. announced today that on June 26, Health Canada approved Pradaxa (dabigatran etexilate) for the treatment of venous ...

Because CADTH has cleared the backlog of CDR applications, there is no longer a rationale for the priority review process, ...

The Abbott Government remains committed to accepting the expert advice of Australia’s independent Pharmaceutical Benefits Advisory Committee (PBAC) without ‘fear ...

PHARMAC is seeking feedback on a proposal to remove or amend the funding restrictions for a number of pharmaceuticals from ...

12 November 2014 - More than 40 cancer drugs being paid for out of the government’s Cancer Drugs Fund are to be reassessed ...

[:content [\3 \1 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  " ..."]]